Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg
For AI Exposure, Try Global Artificial Intelligence ETF

Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock

For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg
For AI Exposure, Try Global Artificial Intelligence ETF

Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock

For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg
For AI Exposure, Try Global Artificial Intelligence ETF

Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock

For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg
For AI Exposure, Try Global Artificial Intelligence ETF

Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock

Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge: https://www.marketbeat.com/logos/articles/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge

The story of Netflix Inc.'s (NASDAQ: NFLX) turnaround potential is getting investors' attention. The streamer's stock is up 23.71% in the past month, gapping up on May 18 following news that it

Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge: https://www.marketbeat.com/logos/articles/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge

The story of Netflix Inc.'s (NASDAQ: NFLX) turnaround potential is getting investors' attention. The streamer's stock is up 23.71% in the past month, gapping up on May 18 following news that it

Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge: https://www.marketbeat.com/logos/articles/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge

The story of Netflix Inc.'s (NASDAQ: NFLX) turnaround potential is getting investors' attention. The streamer's stock is up 23.71% in the past month, gapping up on May 18 following news that it

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring: https://www.marketbeat.com/logos/articles/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg
Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring

Dynatrace Inc. (NYSE: DT) has been a strong performer recently, benefiting from the market's optimism about the company’s AI technologies, as well as its network monitoring services.

A glimpse of

Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring: https://www.marketbeat.com/logos/articles/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg
Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring

Dynatrace Inc. (NYSE: DT) has been a strong performer recently, benefiting from the market's optimism about the company’s AI technologies, as well as its network monitoring services.

A glimpse of

OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?: https://www.marketbeat.com/logos/articles/med_20230605102956_opec3.png
OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?

In a surprising move, Saudi Arabia pledged to reduce its oil output by 1 million barrels per day for July at the June 4 OPEC meeting. This adjustment, which may continue monthly, places Saudi oil

OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?: https://www.marketbeat.com/logos/articles/med_20230605102956_opec3.png
OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?

In a surprising move, Saudi Arabia pledged to reduce its oil output by 1 million barrels per day for July at the June 4 OPEC meeting. This adjustment, which may continue monthly, places Saudi oil

OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?: https://www.marketbeat.com/logos/articles/med_20230605102956_opec3.png
OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?

In a surprising move, Saudi Arabia pledged to reduce its oil output by 1 million barrels per day for July at the June 4 OPEC meeting. This adjustment, which may continue monthly, places Saudi oil

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Here’s Why Disney’s MCU is Sinking in Quicksand: https://www.marketbeat.com/logos/articles/med_20230604133550_chart-dis2.jpg
Here’s Why Disney’s MCU is Sinking in Quicksand

Media and entertainment giant The Walt Disney Company (NYSE: DIS) has seen a continued decline in its Disney+ subscribers and live-action box office debuts. Disney+ lost four million subscribers